NDA names Jaswant Singh as its vice-presidential candidate

July 16, 2012

jaswant

New Delhi, July 16: Bharatiya Janata Party (BJP) leader Jaswant Singh was today chosen by the National Democratic Alliance (NDA) as its unanimous candidate for the August 7 Vice-Presidential election against UPA nominee Hamid Ansari.

The opposition alliance said it had reservations over the re-nomination of Mr Ansari, particularly the manner in which he conducted the Rajya Sabha when the Lokpal Bill was discussed and the Women’s Reservation Bill was passed.

“We have decided not to give them (UPA) a walkover... We have unanimously decided that Jaswant Singh will be the NDA candidate in the Vice-Presidential poll,” L K Advani, NDA Working President, announced after an NDA meeting.

Mr Advani said JD(U) chief Sharad Yadav had also raised concerns over Mr Ansari’s conduct in the passage of the Women’s Reservation Bill in the Rajya Sabha where marshals were used to oust those opposed to the legislation.

He said the same concerns were shared with Prime Minister Manmohan Singh when he had called him on Saturday to seek support for Mr Ansari’s candidature.

Mr Advani said Mr Yadav, also the NDA convenor, was initially approached to contest the Vice Presidential election, but he declined citing his interest in active politics.

The BJP leader indicated that the NDA would reach out to all such parties which have not committed their support to the UPA nominee.

Reacting to his nomination, 74-year-old Jaswant Singh said, “It is a matter of great respect that the NDA has unanimously chosen me as their candidate for the post of Vice President. It is a big responsibility and also a challenge”.


Earlier:

Jaswant or Sharad for VP race? NDA to decide today

New Delhi, July 16: Even while toying with the idea of making senior leader Jaswant Singh contest for the post of vice-president, BJP is not likely to take any decision until it has full knowledge of the likely stand of regional satraps Mamata Banerjee, J Jayalalitha and Naveen Patnaik. Sources said the NDA meeting on Monday morning will take a call on whether or not to formally announce the candidature of Singh who seems to be keen to contest.

While BJP is said to have even contemplated fielding NDA convener and JD(U) leaderSharad Yadav, he refused to talk about it saying the picture would become clear only after the meeting on Monday. Yadav, however, did say that the vice-presidential polls were different from the elections for president in which JD(U) has gone its own way by supporting Pranab Mukherjee.

"The issue of vice-presidential election and Pranab Mukherjee are separate. I have never supported Congress's political line since I joined politics. We have supported Mukherjee for his political experience only," Yadav told reporters. This has been interpreted by some as an indication of support for BJP in case it decides to contest but Yadav did not confirm this saying that all options were still open.

Later in the evening, he told TOI that it would be wrong to say BJP had already made up its mind to contest and that the final decision would be taken only after the meeting. Shiv Sena has already announced support for the NDA candidate.

Sources said that with Banerjee's choice Gopal Gandhi declining to contest, Jaswant may have to take the field if Jayalalitha and Patnaik fail to come up with a candidate to put up a token fight.

PM Manmohan Singh had called Yadav for JD(U) support but he remained non-committal. UPA candidate Hamid Ansari can sail through even without support from Banerjee, one of the reasons why Yadav doesn't seem keen to contest. While BJP's Najma Heptullah too is said to be keen to contest, sources said the outcome would hinge on the stand taken by smaller parties like Patnaik's BJD and Jayalalitha's AIADMK. "The party may decide to support their candidate to ensure a decent contest," said a leader.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 29,2020

New Delhi, Apr 29: India's tally of COVID-19 cases has reached 31,332, said the Union Ministry of Health and Family Welfare on Wednesday. With 73 more deaths reported, the number of deaths due to coronavirus in the country breached the 1,000 mark and stood at 1,007.

The tally is inclusive of 22,629 active coronavirus cases, 7,695 patients who have been cured/discharged and one patient migrated.

According to the Ministry, Maharashtra has the most number of COVID-19 cases with 9,318 cases of which, 1,388 patients have been cured/discharged while 400 patients have succumbed to the virus.

Gujarat has the second-highest number of positive cases in the country with 3744 cases including 434 patients cured/discharged and 181 deaths.

Delhi's tally stands at 3314 cases of which, 1078 patients have recovered while 54 patients have succumbed to the virus.

Madhya Pradesh has a total of 2387 positive cases including 377 patients recovered/discharged and 120 fatalities.

Meanwhile, Goa (seven cases; all seven recovered), Arunachal Pradesh (one case; now recovered), Manipur (two cases; both recovered), Tripura (two cases; both recovered) have reported no new cases of COVID-19.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 26,2020

New Delhi, Jun 26: With the highest single-day spike of 17,296 COVID-19 cases reported in the last 24 hours, India's COVID-19 count reached 4,90,401 on Friday, said the Union Ministry of Health and Family Welfare (MoHFW).

The country also saw 407 deaths in the last 24 hours, which pushed the death toll to 15,301.

The total number of cases includes 1,89,463 active cases, 2,85,637cured/discharged/migrated cases, as per the MoHFW.

According to the Indian Council of Medical Research (ICMR), the total number of samples tested up to June 25 is 77,76,228; the number of samples tested on 25 June is 2,15,446.

Maharashtra remains the worst-affected state in the country with 1,47,741 cases. The active cases in the state are 63,357. The number of people cured or discharged stands at 77,453 while the death toll is at 6,931.

Delhi has so far reported 73,780 cases. The active cases in the national capital stood at 26,586. While the cured and discharged numbers stood at 44,765. The death toll in the city is 2,429.

Tamil Nadu has so far reported 70,977. With active cases at 30,067 and the number of cured or discharged at 39,999, while the death toll stood at 911.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.